Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
BBNXthis companyBeta Bionics, Inc.	$16.64	-16.83×	4.29×	12.32×	-17.22×	-1006.1%	55.4%	-71.5%	-73.0%	-25.5%	-23.9%	-4.6%	0.03×	0.35×	0×	8.66×	0.0%	3	9.08	2	C
DXCMDexCom, Inc.	$79.83	31.01×	9.43×	5.56×	19.41×	-50.0%	60.1%	19.6%	17.9%	30.5%	16.6%	4.2%	0.51×	0.35×	49.83×	1.88×	0.0%	8	7.49	3	B+
MMEDMiniMed Group, Inc.	$17.39	-10.23×	0.94×	1.09×	15.78×	-234.6%	54.2%	1.6%	-10.7%	-9.2%	1.2%	-12.4%	0.04×	-0.75×	0×	1.92×	0.0%	2	3.72	3	B
MNKDMannKind Corporation	$4.14	283.5×	-33.97×	4.97×	77.45×	-1108.3%	82.5%	11.1%	1.7%	-11.5%	5.8%	0.8%	-9.28×	14.48×	2.81×	1.7×	0.0%	1	-4.55	2	C+
ORMPOramed Pharmaceuticals Inc.	$3.96	1.86×	0.59×	59×	0.97×	-70.9%	0.7%	-754.4%	3202.5%	32.1%	-6.0%	-9.4%	0×	-0.6×	0×	6.98×	0.0%	3	3.38	5	S-
PODDInsulet Corp.	$146.86	80.98×	13.2×	7.38×	39.89×	-125.0%	71.6%	17.5%	9.1%	16.3%	13.6%	1.9%	0.69×	0.66×	5.94×	2.78×	0.0%	9	5.84	3	B
Peer median	—	31.01×	0.94×	5.56×	19.41×	-125.0%	60.1%	11.1%	9.1%	16.3%	5.8%	0.8%	0.04×	0.35×	2.81×	1.92×	0.0%	3	3.72	3	—